VB-AI: AI Driven Quantification of Brain Bleeds for Decision Support in Stroke And Trauma Care
VB-AI is an AI-aided diagnostic software designed to serve as a decision-support tool for qualified clinical professionals. It detects ventricular bleeds (VB) and assesses their severity by providing quantitative measurements. The software's goal is to reduce response times, improve efficiency and accuracy, and assist in determining appropriate treatment strategies.
Business Opportunity
Stroke is a leading cause of death and disability worldwide, with intracerebral hemorrhage (ICH) complicated by intraventricular hemorrhage (IVH) posing a major challenge. Beyond stroke, IVH is also a critical prognostic factor in traumatic brain injury (TBI). Current manual IVH assessments are slow, inconsistent, and highly variable, highlighting the urgent need for faster, standardized tools. VB-AI fills this gap with automated IVH quantification from CT scans, providing rapid, accurate, and consistent results. By streamlining workflows and reducing variability, it enables earlier and more confident intervention decisions in acute stroke care. At the crossroads of AI diagnostics and medical imaging, VB-AI offers strong licensing potential to imaging companies and AI providers seeking clinically validated, scalable solutions. Looking for licensing partners: We are seeking licensing partners to integrate VB-AI into established product portfolios and accelerate commercialization in global stroke and trauma imaging markets.
Technology Description
VB-AI leverages a cutting-edge AI technology to transform the diagnosis and management of intraventricular hemorrhage (IVH), a life-threatening condition often linked to poor neurological outcomes. Traditional manual scoring methods are slow and inconsistent, while existing imaging techniques like MRI are not suited for the urgent nature of acute care. Our innovation introduces a novel approach - using CT imaging to automatically quantify IVH volume and severity, delivering instant, standardized scoring that enhances communication across clinical teams. By automating this critical process, VB-AI empowers faster and more accurate decision-making, enabling timely interventions that improve patient outcomes and streamline care pathways. This technology has the potential to set a new standard in the diagnosis, prognosis, and treatment of acute brain bleeds.
Fig. 1: Overview of VB-AI as a decision support tool for ICH
Intellectual Property
Patent pending